The 3D product is being rolled out in 10 USA hospitals. As word gets out it should be 15 hospitals including Canada in another year. In Europe lets concentrate mainly on the CHD neonatal area where we have the 2 best repair products with high mark up. With EU approval we should have 20 hospitals using the products. My target is 100 hospitals. Australia 4, Japan 4, Singapore South Korea, the rest of Asias small countries and finally China and India making up the numbers. I would visualise that Chinas hospitals work 7 days per week on routine repair vascular work as would India unless they got into a cricket final. Seriously the money and our advantage is with this work. Get Europe up and operational. I wonder what the EU issues are as referred by WP? Any comment on the possible issues.
The 3D product is being rolled out in 10 USA hospitals. As word...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.64 |
Change
-0.360(2.40%) |
Mkt cap ! $311.5M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.00 | $14.50 | $43.27K | 2.949K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 150 | $14.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.64 | 150 | 1 |
View Market Depth
| Last trade - 12.47pm 15/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |